BBNX Sale Disclosure
Hopman Mark · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$6.25K
Hopman Mark Chief Commercial Officer
BBNX
Beta Bionics
BBNX
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
BBNX daily price context
Close on/before transaction
$15.9
Nov 2, 2026
First close after public filing
$15.49
Nov 5, 2026
Return after filing · so far
+1.36%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 370 shares @ $16.9
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002048497-26-000025
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$6.25K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beta Bionics, Inc. BBNX Current | Sale | Nov 2, 2026 | $6.25K |